Nevisense
Creating a new standard in skin barrier assessment
![iStock-1137515007 [Converted]](https://barrier.scibase.com/wp-content/uploads/2022/10/istock-1137515007-converted.webp)
The challenge:
Researchers simply do not have the tools to identify skin barrier function in a simple, objective manner.
20% of infants develop AD
They are up to 7 times more likely to develop asthma and allergies.
7% of adults suffer from atopic diseases
40% of them experience chronic symptoms, and some of those debilitating pain.
Skin Barrier Assessment: A new level of insight
Nevisense Skin Barrier Assessment brings new level of insight into the skin barrier fuction, contributing to studies involving inflammation and allergy, wound healing, and even cosmetics.
Nevisense
- Effective, efficient and Reproducible
- AI-driven
- 20+ years of research and 85+ publications
- More robust than TEWL, and less sensitive to artifacts
Why the skin barrier matters
Skin Barrier dysfuction is closely connected to diseases such as atopic dermatitis (AD), asthma, chronic rhinosinusitis, allergic rhinitis, esophagitis, and colitis.
Publication
Nevisense detects skin barrier dysfunction in children with Atopic Dermatitis
Publication
Nevisense characterizes skin barrier function in Atopic Dermatitis patients
"I work every day with the management of different allergic diseases in children, and it is a growing problem. Allergic diseases have a natural progression with atopic dermatitis being the first to manifest, often already in infancy, followed by other allergic diseases, such as food allergy and allergic asthma. The ability to identify these children early will help to develop preventive strategies for allergic diseases, and Nevisense is an extremely promising method that has potential for early prediction of those children."
Dr. Caroline Roduit
PD Dr. med., PhD, University of Zurich | UZH · Children’s Hospital of Eastern Switzerland.
Our corporate site
Visit scibase.com to learn more on how Nevisense is beeing used in all indications.
Our Investor site
Visit our investor site to learn more on oppertinities with SciBase and Nevisense.
Publications
Nevisense has been included in over 85 published studies. Download our publication list here.
Nevisense: a new objective standard to measure and manage skin barrier fuction.
Contact us
"*" indicates required fields